申请人:CHEMEX/BLOCK DRUG, JV
公开号:EP0836852A1
公开(公告)日:1998-04-22
The use of amlexanox, or a homologue or analogue of amlexanox, in the manufacture of a medical composition for the treatment of aphthous ulcers, wherein amlexanox has the formula:
wherein R1 is hydrogen, alkyl, phenyl, carboxyl, hydroxyl, alkoxyl, carboxyalkyl such as esters, cyano, acylamino, or amino which may be unsubstituted or substituted by up to two alkyl groups; m is 0, 1, or 2; R2 is alkyl, alkenyl, alkoxy, halogen, nitro, hydroxy, carboxyl, butadienylene (-CH=CH-CH=CH-) which forms a benzene ring with any adjacent carbon atoms, cyano, carboxyalkyl, trifluoromethyl, or amino which may be unsubstituted or substituted by at least one alkyl group; and R3 is carboxyl, cyano, arylalkoxycarbonyl, alkoxycarbonyl, or carboxamide, which may be unsubstituted or substituted by at least one alkyl group, and the salts thereof.
氨来呫诺或氨来呫诺的同系物或类似物在制造治疗阿弗他溃疡的医用组合物中的用途,其中氨来呫诺具有以下式子:
其中 R1 是氢、烷基、苯基、羧基、羟基、烷氧基、羧基烷基如酯、氰基、酰氨基或氨基,它们可以是未取代的或最多被两个烷基取代的;m 是 0、1 或 2;R2 是烷基、烯基、烷氧基、卤素、硝基、羟基、羧基、与任何相邻碳原子形成苯环的丁二烯基(-CH=CH-CH=CH-)、氰基、羧基烷基、三氟甲基或氨基,它们可以未被取代或被至少一个烷基取代;和 R3 是羧基、氰基、芳基烷氧基羰基、烷氧基羰基或羧酰胺,它们可以未被取代或被至少一个烷基取代,以及它们的盐。